Lung Cancer Likelihood in Plasma (Lung-CLiP)

Lung-CLiP is a novel approach from the Alizadeh Lab and the Diehn Lab developed by Chabon, Hamilton, Kurtz, Shahrokh, et al. for noninvasive early NSCLC detection that integrates improved sequencing library preparation and machine learning to predict the presence of tumor-derived cfDNA in a blood sample.